Interlude Biopharma Co.
Records under this name other than the patents Interlude Biopharma Co. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 15 patents it holds.
Showing 1 to 2 of 2 · Back to Interlude Biopharma Co.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,796,203 | Use of Tight Junction Antagonists to Treat Inflammatory Bowel Disease Lapsed on the fee record Ended Aug 5, 2026 · High confidence | Lapsed on the fee record | Ended Aug 5, 2026 | High confidence |
| US 8,299,017 | Use of Tight Junction Antagonists to Treat Inflammatory Bowl Disease Lapsed on the fee record Ended Oct 30, 2024 · High confidence | Lapsed on the fee record | Ended Oct 30, 2024 | High confidence |